New York Life Investment Management LLC Trims Stock Position in Intuitive Surgical, Inc. $ISRG

New York Life Investment Management LLC trimmed its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 52,361 shares of the medical equipment provider’s stock after selling 1,345 shares during the period. New York Life Investment Management LLC’s holdings in Intuitive Surgical were worth $23,417,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Tobam lifted its holdings in shares of Intuitive Surgical by 666.7% in the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 40 shares during the last quarter. Kilter Group LLC acquired a new position in Intuitive Surgical during the second quarter worth approximately $27,000. Princeton Global Asset Management LLC acquired a new stake in shares of Intuitive Surgical in the second quarter valued at approximately $30,000. Greykasell Wealth Strategies Inc. acquired a new position in shares of Intuitive Surgical in the 3rd quarter valued at $27,000. Finally, Riggs Asset Managment Co. Inc. boosted its stake in Intuitive Surgical by 84.2% during the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock worth $38,000 after purchasing an additional 32 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

ISRG has been the subject of a number of research reports. Argus reduced their target price on shares of Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a report on Wednesday, February 4th. Wall Street Zen lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Saturday. Raymond James Financial upped their price target on Intuitive Surgical from $603.00 to $615.00 and gave the stock an “outperform” rating in a research note on Friday, January 23rd. Daiwa Securities Group lifted their price objective on shares of Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a research report on Friday, October 24th. Finally, Royal Bank Of Canada boosted their price objective on shares of Intuitive Surgical from $625.00 to $650.00 and gave the company an “outperform” rating in a research note on Wednesday, December 17th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $617.23.

Insiders Place Their Bets

In related news, EVP Myriam Curet sold 230 shares of the business’s stock in a transaction dated Tuesday, January 27th. The shares were sold at an average price of $532.61, for a total value of $122,500.30. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Craig H. Barratt sold 750 shares of Intuitive Surgical stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total transaction of $435,000.00. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 70,011 shares of company stock valued at $38,858,275. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $488.15 on Monday. The stock’s 50 day moving average price is $549.63 and its 200 day moving average price is $510.60. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $609.08. The company has a market cap of $173.36 billion, a PE ratio of 61.87, a price-to-earnings-growth ratio of 3.79 and a beta of 1.65.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The company had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. During the same period in the previous year, the firm earned $2.21 EPS. The business’s revenue was up 18.8% on a year-over-year basis. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.